Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR 1,900.90
-0.10 (-0.01%)
At close: Aug 21, 2026
BOM:524715 Market Cap
BOM:524715 has a market cap or net worth of 4.56 trillion as of August 21, 2026. Its market cap has increased by 16.49% in one year.
Market Cap
4.56T
Enterprise Value
4.28T
Revenue
599.11B
Ranking
n/a
PE Ratio
37.74
Stock Price
1,900.90
ChartMarket Cap Chart
Since February 15, 2001, BOM:524715's market cap has increased from 27.61B to 4.56T, an increase of 16,431.62%. That is a compound annual growth rate of 22.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.56T | 10.62% |
| Dec 31, 2025 | 4.13T | -8.83% |
| Dec 31, 2024 | 4.53T | 49.78% |
| Dec 29, 2023 | 3.02T | 25.77% |
| Dec 30, 2022 | 2.40T | 18.41% |
| Dec 31, 2021 | 2.03T | 42.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.86T |
| Lupin | 1.00T |
| Dr. Reddy's Laboratories | 978.76B |
| Abbott India | 557.70B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 212.72B |